These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 30473376

  • 21. Genetic Regulation of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Plasma Levels and Its Impact on Atherosclerotic Vascular Disease Phenotypes.
    Pott J, Schlegel V, Teren A, Horn K, Kirsten H, Bluecher C, Kratzsch J, Loeffler M, Thiery J, Burkhardt R, Scholz M.
    Circ Genom Precis Med; 2018 May; 11(5):e001992. PubMed ID: 29748315
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of PCSK9 levels and its genetic polymorphisms in women with polycystic ovary syndrome.
    Xavier LB, Sóter MO, Sales MF, Oliveira DK, Reis HJ, Candido AL, Reis FM, Silva IO, Gomes KB, Ferreira CN.
    Gene; 2018 Feb 20; 644():129-136. PubMed ID: 29109005
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Differential Expression of PCSK9 Modulates Infection, Inflammation, and Coagulation in a Murine Model of Sepsis.
    Dwivedi DJ, Grin PM, Khan M, Prat A, Zhou J, Fox-Robichaud AE, Seidah NG, Liaw PC.
    Shock; 2016 Dec 20; 46(6):672-680. PubMed ID: 27405064
    [Abstract] [Full Text] [Related]

  • 27. Loss-of-function/gain-of-function polymorphisms of the ATP sensitive P2X7R influence sepsis, septic shock, pneumonia, and survival outcomes.
    Guggemos J, Fuller SJ, Skarratt KK, Mayer B, Schneider EM.
    Front Immunol; 2024 Dec 20; 15():1352789. PubMed ID: 38966639
    [Abstract] [Full Text] [Related]

  • 28. Complexity of mechanisms among human proprotein convertase subtilisin-kexin type 9 variants.
    Dron JS, Hegele RA.
    Curr Opin Lipidol; 2017 Apr 20; 28(2):161-169. PubMed ID: 28157721
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. PCSK9 loss of function is protective against extra-coronary atherosclerotic cardiovascular disease in a large multi-ethnic cohort.
    Small AM, Huffman JE, Klarin D, Lynch JA, Assimes T, DuVall S, Sun YV, Shere L, Natarajan P, Gaziano M, Rader DJ, Wilson PWF, Tsao PS, Chang KM, Cho K, O'Donnell CJ, Casas JP, Damrauer SM, VA Million Veteran Program.
    PLoS One; 2020 Apr 20; 15(11):e0239752. PubMed ID: 33166319
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Circulating proprotein convertase subtilisin-kexin type 9, all-cause mortality, and cardiovascular mortality: The Ludwigshafen Risk and Cardiovascular Health study.
    Silbernagel G, Scharnagl H, Kleber ME, Stojakovic T, März W.
    Eur J Prev Cardiol; 2017 Jul 20; 24(10):1095-1101. PubMed ID: 28436724
    [Abstract] [Full Text] [Related]

  • 35. Elevated circulating PCSK9 level is associated with 28-day mortality in patients with sepsis: a prospective cohort study.
    Shu Y, Deng Z, Deng Y, Zhou J, Wang J, Duan Z, Jiang T, Zhao X, Shi Z, Qiu C.
    BMC Emerg Med; 2023 Oct 31; 23(1):127. PubMed ID: 37904138
    [Abstract] [Full Text] [Related]

  • 36. Proprotein convertase subtilisin/kexin 9 V4I variant with LDLR mutations modifies the phenotype of familial hypercholesterolemia.
    Ohta N, Hori M, Takahashi A, Ogura M, Makino H, Tamanaha T, Fujiyama H, Miyamoto Y, Harada-Shiba M.
    J Clin Lipidol; 2016 Oct 31; 10(3):547-555.e5. PubMed ID: 27206942
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Role of lipoproteins and proprotein convertase subtilisin/kexin type 9 in endotoxin clearance in sepsis.
    Walley KR.
    Curr Opin Crit Care; 2016 Oct 31; 22(5):464-9. PubMed ID: 27552305
    [Abstract] [Full Text] [Related]

  • 39. The effect of APOE, CETP, and PCSK9 polymorphisms on simvastatin response in Thai hypercholesterolemic patients.
    Wanmasae S, Sirintronsopon W, Porntadavity S, Jeenduang N.
    Cardiovasc Ther; 2017 Dec 31; 35(6):. PubMed ID: 28851085
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.